Increased GITR expression has been shown to be a positive prognostic factor in endometrial carcinoma and head and neck tumors, whereas the opposite has been confirmed in renal carcinoma [72, 73, 75]. The gene discussed is TNFRSF18; the disease is endometrial carcinoma.